Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia

Journal of Clinical Investigation

Volumn 104, Issue 5, 1999, Pages 619-628

  Norman, Dennis ^a   Sun, Xi Ming ^a   Bourbon, Mafalda ^a   Knight, Brian L ^a   Naoumova, Rossitza P ^a   Soutar, Anne K ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CELL TRANSPORT; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOPROTEIN BLOOD LEVEL; MALE; PATHOPHYSIOLOGY; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR BINDING; RECEPTOR GENE;

EID: 0032728972     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6677     Document Type: Article

References (34)

1. Goldstein, J.L., Hobbs, H., and Brown, M.S. 1995. Familial hypercholesterolemia. In The Metabolic and molecular bases of inherited disease. C.R. Scriver et al., editors. McGraw-Hill. NewYork, NY. 1981-2030.
2. Sun, X.M., Patel, D.D., Knight, B.L., and Soutar, A.K. 1998. Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolemia. The Familial Hypercholesterolaemia Regression Study Group. Atherosclerosis. 136:175-185.
3. Sun, X.M., Patel, D.D., Knight, B.L., and Soutar, A.K. 1997. Comparison of the genetic defect with LDL-receptor activity in cultured cells from patients with a clinical diagnosis of heterozygous familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 17:3092-3101.
4. Pimstone, S.N., et al. 1998. Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada. Arterioscler. Thromb. Vasc. Biol. 18:309-315.
5. Day, I., et al. 1997. Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia. Hum. Mutat. 10:116-127.
6. Rallidis, L., Nihoyannopoulos, P., and Thompson, G.R. 1996. Aortic stenosis in homozygous familial hypercholesterolaemia. Heart. 76:84-85.
7. Sun, X.M., Patel, D.D., Bhatnagar, D., Knight, B.L., and Soutar, A.K. 1995. Characterization of a splice-site mutation in the gene for the LDL receptor associated with an unpredictably severe clinical phenotype in English patients with heterozygous FH. Arterioscler. Thromb. Vasc. Biol. 15:219-227.
8. Soutar, A.K., Knight, B.L., and Patel, D.D. 1989. Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors. Proc. Natl. Acad. Sci. USA.. 86:4166-4170.
9. Webb, J.C., et al. 1992. Characterization of two new point mutations in the low density lipoprotein receptor genes of an English patient with homozygous familial hypercholesterolemia. J. Lipid. Res. 33:689-698.
10. Sun, X.M., et al. 1992. Characterization of deletions in the LDL receptor gene in patients with familial hypercholesterolemia in the United Kingdom. Arterioscler. Thromb. 12:762-770.
11. Day, I., et al. 1997. Identification of a common low density lipoprotein receptor mutation (r329x) in the south of England: complete linkage disequilibrium with an allele of microsatellite d19s394. J. Med. Genet. 34:111-116.
12. Knight, B.L., Gavigan, S.J., Soutar, A.K., and Patel, D.D. 1989. Defective processing and binding of low-density lipoprotein receptors in fibroblasts from a familial hypercholesterolaemic subject. Eur. J. Biochem. 179:693-698.
13. Soutar, A.K., and Knight, B.L. 1986. Immunoprecipitation of the low-density-lipoprotein (LDL) receptor and its precursor from human monocyte-derived macrophages. Biochem. J. 233:683-690.
14. Buchegger, F., Trowbridge, I.S., Liu, L.F., White, S., and Collawn, J.F. 1996. Functional analysis of human/chicken transferrin receptor chimeras indicates that the carboxy-terminal region is important for ligand binding. Eur. J. Biochem. 235:9-17.
15. Hopkins, C.R., and Trowbridge, I.S. 1983. Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells. J. Cell Biol. 97:508-521.
16. Leitersdorf, E., and Hobbs, H.H. 1988. Human LDL receptor gene: HinclI polymorphism detected by gene amplification. Nucleic Acids Res. 16:7215.
17. Hobbs, H.H., Esser, V., and Russell, D.W. 1987. AvaII polymorphism in the human LDL receptor gene. Nucleic Acids Res. 15:379.
18. Warnich, L., Kotze, M.J., Langenhoven, E., and Retief, A.E. 1992. Detection of a frequent polymorphism in exon 10 of the low-density lipoprotein receptor gene. Hum. Genet. 89:362.
19. Webb, J.C., Patel, D.D., Shoulders, C.C., Knight, B.L., and Soutar, A.K. 1996. Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein (LDL)-receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolaemia and a common polymorphism. Hum. Mol. Genet. 5:1325-1331.
20. Brown, M.S., and Goldstein, J.L. 1976. Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound low density lipoprotein. Cell. 9:663-674.
21. Pearse, B.M., and Robinson, M.S. 1990. Clathrin, adaptors, and sorting. Annu. Rev. Cell. Biol. 6:151-171.
22. Warren, R.A., Green, F.A., and Enns, C.A. 1997. Saturation of the endocytic pathway for the transferrin receptor does not affect the endocytosis of the epidermal growth factor receptor. J. Biol. Chem. 272:2116-2121.
23. Warren, R.A., Green, F.A., Stenberg, P.E., and Enns, C.A. 1998. Distinct saturable pathways for the endocytosis of different tyrosine motifs. J. Biol. Chem. 273:17056-17063.
24. Marks, M.S., Woodruff, L., Ohno, H., and Bonifacino, J.S. 1996. Protein targeting by tyrosine- and di-leucine-based signals: evidence for distinct saturable components. J. Cell Biol. 135:341-354.
25. Robinson, M.S. 1994. The role of clathrin, adaptors and dynamin in endocyrosis. Curr. Opin. Cell Biol. 6:538-544.
26. Davis, C.G., van Driel, I.R., Russell, D.W., Brown, M.S., and Goldstein, J.L. 1987. The low density lipoprotein receptor. Identification of amino acids in cytoplasmic domain required for rapid endocytosis. J. Biol. Chem. 262:4075-4082.
27. Kibbey, R.G., Rizo, J., Gierasch, L.M., and Anderson, R.G. 1998. The LDL receptor clustering motif interacts with the clathrin terminal domain in a reverse turn conformation. J. Cell Biol. 142:59-67.
28. Ohno, H., Poy, G., and Bonifacino, J.S. 1998. Cloning of the gene encoding the murine clathrin-associated adaptor medium chain mu 2: gene organization, alternative splicing and chromosomal assignment. Gene. 210:187-193.
29. Wolthers, B.C., et al. 1991. Use of determinations of 7-lathosterol (5 alpha-cholest-7-en-3 beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomarosis. J. Lipid. Res. 32:603-612.
30. Zuliani, G., et al. 1995. Severe hypercholesterolaemia: unusual inheritance in an Italian pedigree. Eur. J. Clin. Invest. 25:322-331.
31. Feher, M.D., et al. 1993. Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia Atherosclerosis. 103:171-180.
32. Schmidt, H.H., et al. 1998. Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia. J. Clin. Endocrinol. Metab. 83:2167-2174.
33. Haddad, L., et al. 1999. Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred. J. Lipid Res. 40:1113-1122.
34. Webb, J.C., et al. 1996. Characterization of mutations in the low density lipoprotein (LDL)-receptor gene in patients with homozygous familial hypercholesterolemia, and frequency of these mutations in FH patients in the United Kingdom. J. Lipid. Res. 37:368-381.